Sweden
· Delayed Price · Currency is SEK Spermosens AB Statistics
Total Valuation
Spermosens AB has a market cap or net worth of SEK 9.08 million. The enterprise value is 6.89 million.
| Market Cap | 9.08M |
| Enterprise Value | 6.89M |
Important Dates
The next estimated earnings date is Wednesday, November 20, 2024.
| Earnings Date | Nov 20, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Spermosens AB has 283.61 million shares outstanding. The number of shares has increased by 179.94% in one year.
| Shares Outstanding | 283.61M |
| Shares Change (YoY) | +179.94% |
| Shares Change (QoQ) | +241.93% |
| Owned by Insiders (%) | 1.52% |
| Owned by Institutions (%) | 2.18% |
| Float | 279.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.38 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.62 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.60 |
Financial Position
The company has a current ratio of 1.93, with a Debt / Equity ratio of 3.20.
| Current Ratio | 1.93 |
| Quick Ratio | 1.93 |
| Debt / Equity | 3.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.07 |
| Interest Coverage | -4.04 |
Financial Efficiency
Return on equity (ROE) is -33.55% and return on invested capital (ROIC) is -16.35%.
| Return on Equity (ROE) | -33.55% |
| Return on Assets (ROA) | -15.27% |
| Return on Capital (ROIC) | -16.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.85M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.30% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -96.30% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.24 |
| Relative Strength Index (RSI) | 39.45 |
| Average Volume (20 Days) | 2,628,237 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.88M |
| Pretax Income | -11.08M |
| Net Income | -11.08M |
| EBITDA | -8.71M |
| EBIT | -8.88M |
| Earnings Per Share (EPS) | -0.17 |
Balance Sheet
The company has 2.96 million in cash and 773,000 in debt, giving a net cash position of 2.19 million or 0.01 per share.
| Cash & Cash Equivalents | 2.96M |
| Total Debt | 773,000 |
| Net Cash | 2.19M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 24.13M |
| Book Value Per Share | 0.09 |
| Working Capital | 1.88M |
Cash Flow
In the last 12 months, operating cash flow was -11.43 million and capital expenditures -108,000, giving a free cash flow of -11.54 million.
| Operating Cash Flow | -11.43M |
| Capital Expenditures | -108,000 |
| Free Cash Flow | -11.54M |
| FCF Per Share | -0.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Spermosens AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -179.94% |
| Shareholder Yield | -179.94% |
| Earnings Yield | -525.78% |
| FCF Yield | -127.12% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |